Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone for Post-UAE Inflammation
NCT02056717Completed
- Sponsor
- Severance Hospital
- Start
- Apr 2014
- Primary completion
- Apr 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, double-blind trial of dexamethasone in uterine fibroid and adenomyosis (2 arms), sponsored by Severance Hospital. Primary endpoint: Inflammatory reactions at 24 hours. Started Apr 2014; status: completed.
02
Drugs
dexamethasone
03
Conditions
uterine fibroidadenomyosis
Beyond the preview
Go deeper on NCT02056717.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02056717.